Dyne Therapeutics, Inc. (DYN) vs Precigen, Inc. (PGEN)
Dyne Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. is the larger, with a market value of $3.1B against $2.8B — 1.1× the size. Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −392.8%) and the lower return on invested capital (−1,956.3% vs −24.9%). Across the 14 metrics below, Dyne Therapeutics, Inc. leads on 9 and Precigen, Inc. on 5.
Valuation
Profitability
| Metric | DYN | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 90.67% | 65.16% |
| Operating margin | 0.00% | (46.08%) | 0.00% |
| Net margin | 0.00% | (392.81%) | 0.00% |
| Free cash flow margin | 0.00% | (134.42%) | 0.00% |
| Return on equity | (81.57%) | (9,907.46%) | (57.72%) |
| Return on assets | (60.29%) | (247.40%) | (49.22%) |
| Return on invested capital | (1,956.27%) | (24.87%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack